Stockreport

VYNE Therapeutics and Yarrow Bioscience Announce Merger Agreement [Yahoo! Finance]

VYNE Therapeutics Inc.  (VYNE) 
PDF receptor (“TSHR”) antibody for Graves' disease (“GD”) and thyroid eye disease (“TED”) Yarrow Bioscience is the seventh biotechnology company founded by RTW Investments [Read more]